Search research articles
Contact Us
Filters
Showing results (121-130 of 137) with videos related to
Page
of 14
Sort By:
International Journal of Hematology
|
September 15, 2010
Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study
Sung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
International Journal of Hematology
|
September 5, 2020
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone
Ho Sup Lee, Kihyun Kim, Je-Jung Lee, et al.
Annals of Hematology
|
December 25, 2019
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study)
Jae-Cheol Jo, Ho Sup Lee, Kihyun Kim, et al.
Blood Cancer Journal
|
June 26, 2023
Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation
Dong Won Baek, Joon Ho Moon, Jae Hoon Lee, et al.
Frontiers in Oncology
|
September 7, 2023
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation
Seok Jin Kim, Jae-Cheol Jo, Dok Hyun Yoon, et al.
Blood Research
|
June 9, 2022
Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
Seo-Yeon Ahn, Sang Kyun Son, Gyu Hyung Lee, et al.
Oncotarget
|
December 2, 2017
Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma
Junshik Hong, Seok Jin Kim, Myung Hee Chang, et al.
Cancer Research and Treatment
|
April 25, 2022
Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts
Jun Ho Yi, Seong Hyun Jeong, Seok Jin Kim, et al.
Cancer Research and Treatment
|
January 6, 2022
Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study
Seong Hyun Jeong, Seok Jin Kim, Dok Hyun Yoon, et al.
Haematologica
|
June 6, 2024
Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: results of the multicenter KMMWP2201 study
Ji Hyun Lee, Jimin Choi, Chang-Ki Min, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 137) with videos related to
Sort By:
Page
of 14
International Journal of Hematology
|
September 15, 2010
Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study
Sung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
International Journal of Hematology
|
September 5, 2020
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone
Ho Sup Lee, Kihyun Kim, Je-Jung Lee, et al.
Annals of Hematology
|
December 25, 2019
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study)
Jae-Cheol Jo, Ho Sup Lee, Kihyun Kim, et al.
Blood Cancer Journal
|
June 26, 2023
Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation
Dong Won Baek, Joon Ho Moon, Jae Hoon Lee, et al.
Frontiers in Oncology
|
September 7, 2023
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation
Seok Jin Kim, Jae-Cheol Jo, Dok Hyun Yoon, et al.
Blood Research
|
June 9, 2022
Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
Seo-Yeon Ahn, Sang Kyun Son, Gyu Hyung Lee, et al.
Oncotarget
|
December 2, 2017
Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma
Junshik Hong, Seok Jin Kim, Myung Hee Chang, et al.
Cancer Research and Treatment
|
April 25, 2022
Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts
Jun Ho Yi, Seong Hyun Jeong, Seok Jin Kim, et al.
Cancer Research and Treatment
|
January 6, 2022
Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study
Seong Hyun Jeong, Seok Jin Kim, Dok Hyun Yoon, et al.
Haematologica
|
June 6, 2024
Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: results of the multicenter KMMWP2201 study
Ji Hyun Lee, Jimin Choi, Chang-Ki Min, et al.
Page
of 14